Welcome to our dedicated page for Qualys SEC filings (Ticker: QLYS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Qualys, Inc. filings document the regulatory disclosures of a Delaware software company providing cloud-based IT, security and compliance solutions. Its 8-K reports furnish quarterly and annual financial results, including GAAP and non-GAAP operating measures, guidance and conference-call materials.
Proxy materials cover annual meeting mechanics, Class II director elections, auditor ratification, advisory executive compensation votes and amendments to the 2012 Equity Incentive Plan. The filings also reflect public-company governance, common-stock voting matters and compensation-plan disclosures.
Qualys insider sale reported on Form 4. Director John A. Zangardi sold 1,287 shares of Qualys, Inc. common stock on 08/13/2025 at a reported price of $132.0266 per share. After the sale he beneficially owned 11,034 shares directly and 5 shares indirectly through his son. The form was signed by Bruce Posey by power of attorney on 08/15/2025.
Qualys, Inc. (QLYS) submitted a Form 144 indicating a proposed sale of 1,287 common shares through Charles Schwab on Nasdaq, with an aggregate market value reported as $169,951 and total shares outstanding of 36,095,879. The securities were acquired as vested restricted stock grants on 06/12/2020 and the filing lists a payment classification of equity compensation dated 06/12/2024. The sale is scheduled approximately for 08/13/2025.
This quantity represents about 0.0036% of the outstanding shares, indicating the proposed sale is immaterial to overall share capital. The filer reports no securities sold in the past three months and includes the standard representation that they are not aware of undisclosed material adverse information.
Form 4 — QUALYS, INC. (QLYS) reported by Joo Mi Kim, Chief Financial Officer.
On 08/01/2025 the reporting person had 3,802 common shares withheld to cover tax liability in connection with the vesting of restricted stock units (transaction code F) at a reported value of $130.53 per share. After the withholding the reporting person beneficially owns 95,486 shares (direct). The Form 4 was signed by Bruce Posey by power of attorney for Joo Mi Kim on 08/05/2025. The filing includes an explicit explanation that the shares were withheld for tax withholding related to RSU vesting.
Qualys (QLYS) Form 4: CEO & President Sumedh S. Thakar reported an administrative share withholding on 1-Aug-2025 (Transaction Code F).
- Shares withheld: 6,042 common shares
- Implied price: $130.53 per share (≈ $0.79 million)
- Reason: To satisfy tax obligations related to vesting RSUs (per footnote 1)
- Post-transaction holding: 209,920 shares held directly
This was not an open-market sale and does not alter Thakar’s economic exposure. Such tax-related withholdings are routine and typically carry neutral-to-slightly-negative sentiment only because the share count in public float rises modestly.
Qualys (QLYS) posted solid but decelerating growth for Q2-25. Revenue rose 10.3% YoY to $164.1 M, keeping gross margin at 82.4%. Operating income increased 6.9% to $51.4 M, trimming operating margin to 31.4% (-90 bps). Net income advanced 8% to $47.3 M; diluted EPS reached $1.29 (+10.3% YoY) on a 2.5% lower diluted share count.
Cash & liquidity remain strong. Cash, cash equivalents and marketable securities totalled $621.2 M, up 8% since year-end, despite $89.5 M of share buybacks that reduced outstanding shares to 36.1 M. Operating cash flow grew 6% to $143.4 M YTD; capex was modest at $3.4 M. The company still has $254.6 M left under its $1.4 B cumulative repurchase authorisation.
- Deferred revenue slipped 5.4% vs. Dec-24 to $374.2 M, hinting at softer bookings.
- Expenses: R&D +11.5%, S&M +11.4%, G&A +18.4% YoY; opex growth outpaced revenue, pressuring margins.
- Comprehensive income was reduced by a $4.2 M hedge-related OCI loss.
Overall, Qualys remains highly profitable with robust cash generation, but slower billings momentum and rising costs warrant monitoring.